학술논문
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
Document Type
Article
Author
Source
In The Lancet Oncology December 2019 20(12):1670-1680
Subject
Language
ISSN
1470-2045